文献速递流行病学与生物统计

平均风险人群结肠镜阴性后随访结局:系统综述与荟萃分析

Outcomes at follow-up of negative colonoscopy in average risk population: systematic review and meta-analysis.
PubMed 文献 · BMJ · 2019-11-13

该系统综述与荟萃分析纳入28项研究,评估平均风险人群初次结肠镜阴性后随访结肠镜检出结直肠腺瘤和癌的患病率,按检查间隔和性别分层。结果显示任何肿瘤患病率在1至5年、5至10年、10年以上间隔分别为20.7%、23.0%、21.9%,晚期肿瘤分别为2.8%、3.2%、7.0%,男性各层均高于女性。作者认为阴性结肠镜后10年筛查间隔可能足够,但需更多研究。

要点

  • 阴性结肠镜后5年内任何肿瘤检出率超过20%,但10年内晚期肿瘤罕见。
  • 晚期肿瘤患病率在1至5年、5至10年、10年以上间隔分别为2.8%、3.2%、7.0%。
  • 按间隔和性别分层,男性各层患病率均高于女性。

核心结论

  • 尽管阴性筛查结肠镜后5年内超过20%的参与者检出任何肿瘤,但10年内晚期肿瘤检出罕见。
  • 作者认为当前推荐的阴性结肠镜后10年结肠镜筛查间隔可能足够,但需更多研究以加强相关推荐的经验基础并探究更长间隔。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed、Web of Science和Embase,两位研究者独立提取数据并进行标准化质量评级。
  • 纳入28项研究,包括22项队列研究、5项横断面研究和1项病例对照研究,研究对象为平均结直肠癌风险且既往结肠镜阴性(无腺瘤)的参与者。
  • 分别有17、16和3项研究报告了结肠镜间隔1至5年、5至10年和10年以上的结果。
  • 研究注册号:Prospero CRD42019127842。

主要发现

  • 任何肿瘤的汇总患病率在间隔1至5年为20.7%(95%CI 15.8%至25.5%),5至10年为23.0%(95%CI 18.0%至28.0%),10年以上为21.9%(95%CI 14.9%至29.0%)。
  • 任何晚期肿瘤的汇总患病率在间隔1至5年为2.8%(95%CI 2.0%至3.7%),5至10年为3.2%(95%CI 2.2%至4.1%),10年以上为7.0%(95%CI 5.3%至8.7%)。
  • 7项研究还报告了按性别分层的结果,按间隔和性别分层的汇总估计男性 consistently 高于女性。

关键数值与推荐

  • 任何肿瘤汇总患病率:1至5年20.7%(95%CI 15.8%至25.5%),5至10年23.0%(95%CI 18.0%至28.0%),10年以上21.9%(95%CI 14.9%至29.0%)。
  • 任何晚期肿瘤汇总患病率:1至5年2.8%(95%CI 2.0%至3.7%),5至10年3.2%(95%CI 2.2%至4.1%),10年以上7.0%(95%CI 5.3%至8.7%)。

临床怎么用

  • 作者认为阴性结肠镜后10年结肠镜筛查间隔可能足够,但需更多研究以加强经验基础并探究更长间隔。

局限性

  • 作者指出需要更多研究以加强相关推荐的经验基础并探究更长间隔。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To review and summarise the evidence on the prevalence of colorectal adenomas and cancers at a follow-up screening colonoscopy after negative index colonoscopy, stratified by interval between examinations and by sex. DESIGN: Systematic review and meta-analysis of all available studies. DATA SOURCES: PubMed, Web of Science, and Embase. Two investigators independently extracted characteristics and results of identified studies and performed standardised quality ratings. ELIGIBILITY CRITERIA: Studies assessing the outcome of a follow-up colonoscopy among participants at average risk for colorectal cancer with a negative previous colonoscopy (no adenomas). RESULTS: 28 studies were identified, including 22 cohort studies, five cross sectional studies, and one case-control study. Findings for an interval between colonoscopies of one to five, five to 10, and more than 10 years were reported by 17, 16, and three studies, respectively. Summary estimates of prevalences of any neoplasm were 20.7% (95% confidence interval 15.8% to 25.5%), 23.0% (18.0% to 28.0%), and 21.9% (14.9% to 29.0%) for one to five, five to 10, and more than 10 years between colonoscopies. Corresponding summary estimates of prevalences of any advanced neoplasm were 2.8% (2.0% to 3.7%), 3.2% (2.2% to 4.1%), and 7.0% (5.3% to 8.7%). Seven studies also reported findings stratified by sex. Summary estimates stratified by interval and sex were consistently higher for men than for women. CONCLUSIONS: Although detection of any neoplasms was observed in more than 20% of participants within five years of a negative screening colonoscopy, detection of advanced neoplasms within 10 years was rare. Our findings suggest that 10 year intervals for colonoscopy screening after a negative colonoscopy, as currently recommended, may be adequate, but more studies are needed to strengthen the empirical basis for pertinent recommendations and to investigate even longer intervals. STUDY REGISTRATION: Prospero CRD42019127842.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Heisser T, Peng L, Weigl K, et al. Outcomes at follow-up of negative colonoscopy in average risk population: systematic review and meta-analysis. BMJ. 2019. PMID: 31722884. doi:10.1136/bmj.l6109

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。